Quadria Group announced the launch of HealthQuad Fund III, with a proposed raise of up to $300 million (target corpus of $200 million with a $100 million greenshoe option). As a successor to Funds I and II, the third fund seeks to build on a proven track record of identifying and scaling pioneering healthcare ventures that have expanded access, affordability, and quality of care across India.
Incubated in 2016, HealthQuad was an initiative by the Quadria Group to create a distinct investment vehicle—separate from its flagship fund—focused on backing disruptive, tech-enabled healthcare models at the early-growth stage. Funds I and II backed over 18 companies including Qure.ai, Medikabazaar, THB, Wysa, Ekincare, Redcliffe Labs, GoApptiv, and Strand Life Sciences, many of which have gone on to become category leaders.
As part of this next chapter, Quadria group, through Dr Amit Varma, Abrar Mir, and Sunil Thakur will assume full ownership and control of the platform following its separation from KOIS. Quadria group has retained a large part of existing investment and investment committee team members who will continue to be involved in the existing portfolio investments.
Further, Quadria group will be strengthening the team through the addition of seasoned investing, operating and clinical team that will be shortly announced.
Quadria group intends to leverage its access to large institutional investor pool across global and domestic investor pool who have shown interest in investing in an integrated platform.
Through this new fund, Quadria Group intends to combine its pan-Asian network, institutional investor base, and operational expertise to deliver scaled impact and value. The Group recently closed Quadria Capital Fund III at $1.07 billion, with strong backing from leading global institutions.
